Skip to main content
Caplight Logo









YourChoice Therapeutics

YourChoice Therapeutics

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.yourchoicetx.com/

Last Round

Grant

Mar 27, 2024

Est. Valuation

$2.14M

Total Funding Raised

$15.65M

Company Overview

YourChoice Therapeutics is a clinical-stage biopharmaceutical company that develops non-hormonal, oral contraceptive products for men and women.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

male contraceptivemale birth controlnon-hormonal contraceptivebiopharmaceuticaldrug discoveryclinical trialsreproductive healthreversible contraceptionYCT-529oral contraceptivemale pillRAR-alpha inhibitorbiotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

YourChoice Therapeutics Comparables

Compare YourChoice Therapeutics with similar companies based on industry and business-model similarity.

YourChoice Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Nuapoch, Inc.
83%
Next Life Sciences
82%
Contraline
68%

YourChoice Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMar 27, 2024
Series AJul 1, 2022
AcceleratorMar 14, 2019

Key People

Founding team and executive leadership

Akash Bakshi

Chief Executive Officer

Executive Team

YourChoice Therapeutics Investors

Notable investors and investment history

YourChoice Therapeutics investors
InvestorRounds
Male Contraceptive InitiativeSeries A, Grant
Refactor CapitalSeries A
Future VenturesSeries A
PortfoliaSeries A
Y CombinatorAccelerator
RH CapitalSeries A
North South VenturesSeries A

YourChoice Therapeutics Filings

Explore SEC and related filing metadata, where available.

YourChoice Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about YourChoice Therapeutics's valuation, stock price, and market status.

Is YourChoice Therapeutics a public or private company?

YourChoice Therapeutics is a private company.

What is the current stock price of YourChoice Therapeutics?

YourChoice Therapeutics is a private company with no public stock price. No recent secondary market data is available.

How much is YourChoice Therapeutics worth (valuation)?

Valuation information for YourChoice Therapeutics is not publicly available.

Can I buy YourChoice Therapeutics stock?

YourChoice Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was YourChoice Therapeutics's last funding round?

YourChoice Therapeutics's most recent funding round was Grant on March 27, 2024.

Who are the main investors in YourChoice Therapeutics?

Key investors in YourChoice Therapeutics include Male Contraceptive Initiative, Future Ventures.

Will YourChoice Therapeutics IPO soon?

No public IPO plans have been announced for YourChoice Therapeutics.

How can I track YourChoice Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor YourChoice Therapeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range6
Year Founded2018
Last FundingMar 27, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?